digital health companies glp-1 programs Technologies enabling long-term outcomes for users GLP-1 Costs Explained: Managing Coverage

Duration and life-stage of antibiotic use and risk of cardiovascular events in women

Furthermore, clinical studies have shown that increased plasma viscosity correlates with poor survival in breast cancer patients [207]

The study results, published in the July 15, 2026, online edition of The Lancet Gastroenterology & Hepatology , address a major unmet need for people with metabolic dysfunctionassociated steatohepatitis (MASH), a serious form of fatty liver disease that can lead to cirrhosis, liver failure, and the need for transplantation

EMA statement on ongoing review of GLP-1 receptor agonists | European Medicines Agency [Internet]

All clinical trials of new medicines in New Zealand require approval from Medsafe and an ethics committee, and Medsafe has not approved any clinical trials in New Zealand for these products